Literature DB >> 2123009

On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes.

W P Schiemann1, J M Walther, I L Buxton.   

Abstract

Adenosine, acting at A1 and A2 purine nucleoside receptors, regulates the physiology of many tissues. Myometrial smooth muscle from pregnant guinea pigs, which is contracted by the actions of adenosine, possesses an A1 receptor whose agonist affinity is regulated by guanine nucleotides. In addition to its expected effect on the affinity of the A1 receptor for agonist, the addition of guanine nucleotide also dramatically increases antagonist binding by as much as 62%. This action of guanine nucleotides on adenosine A1 receptors is common to many smooth muscle preparations and suggests the possibility that GTP-binding proteins might alter the conformation of the adenosine receptor in such a way that receptors not previously able to bind ligands are recruited by the guanine nucleotide. Such an action of guanine nucleotides would alter our general view of the interaction of antagonists with GTP-binding protein coupled receptors, as well as bear significantly on the interpretation of experimental data designed to characterize purinergic receptors. Thus, we have investigated the actions of guanosine-5'-O-[3-thiotriphosphate] on A1 adenosine receptor binding in membranes prepared from pregnant guinea pig myometrium containing 61% right-side-out vesicles. We show that guanosine-5'-O-[3-thiotriphosphate] lowers the affinity of adenosine A1 receptors for agonist in vesicles leading to increased competition of antagonist radioligand for receptor. We suggest that the endogenous adenosine we measure originates from breakdown of significant amounts of adenine nucleotides present in membranes vesicles. Furthermore, we demonstrate that opening membrane vesicles to remove trapped adenosine yields maximal antagonist radioligand binding without subsequent effects of guanosine-5'-O-[3-thiotriphosphate]. We conclude that the presence of endogenous adenosine, unavailable to the actions of adenosine deaminase, is responsible for the effect of guanine nucleotides to increase antagonist binding to adenosine A1 receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123009

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Excitatory motor innervation in the canine rectoanal region: role of changing receptor populations.

Authors:  Stephen D Tichenor; Iain L O Buxton; Paul Johnson; Kate O'Driscoll; Kathleen D Keef
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Differential development of adenosine A1 and A2b receptors in the rat duodenum.

Authors:  J A Peachey; S M Hourani; I Kitchen
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro.

Authors:  A J Chesi; T W Stone
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

4.  Inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate binding sites in smooth muscle.

Authors:  L Zhang; M E Bradley; M Khoyi; D P Westfall; I L Buxton
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations.

Authors:  J A Peachey; S M Hourani; I Kitchen
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

6.  A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.

Authors:  S P Alexander; A R Curtis; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.

Authors:  C Zocchi; E Ongini; S Ferrara; P G Baraldi; S Dionisotti
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

8.  The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.

Authors:  F R Cohen; S Lazareno; N J Birdsall
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.